Search Results 81-90 of 22155 for Antibody

  1. To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients - Mayo Clinic

    To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) ...

  2. Evaluation of Laboratory Methods for Detecting Auto Antibodies to Complement Proteins - Mayo Clinic

    These tests include: Auto antibodies to Factor H; C3 Nephritic Factor; Auto antibodies to C1q; Auto antibodies to C1INH. Participation eligibility.

  3. Overview - Transplant Immunology Program - Mayo Clinic Research

    Overcoming antibody rejection. Refining scientific understanding of kidney pathology. Improving compliance with treatment recommendations. Collaborating with a ...

  4. Convalescent plasma therapy - Mayo Clinic

    ... antibodies. To get ... Data from clinical trials, studies and a national access program suggested that COVID-19 convalescent plasma with high antibody ...

  5. A Study to Assess the Safety, Tolerability and Effectiveness of Monoclonal Antibodies to Treat Hospitalized Patients with COVID-19 - Mayo Clinic

    A Study to Assess the Safety, Tolerability and Effectiveness of Monoclonal Antibodies to Treat Hospitalized Patients with COVID-19. Print details.

  6. Mayo Clinic opens new doors in cancer treatment innovation

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue.

  7. A Multicenter Study To Evaluate The Efficacy And Safety Of Cinryze® For The Treatment Of Acute Antibody-mediated Rejection In Patients With Kidney Transplant - Mayo Clinic

    To evaluate the efficacy of Cinryze® given for the treatment of acute antibody-mediated rejection (of renal allograft) (AMR) in kidney transplant recipients as ...

  8. A Study of ABBV-085, an Antibody Drug Conjugate, for Patients with Advanced Solid Cancer Tumors - Mayo Clinic

    A Study of ABBV-085, an Antibody Drug Conjugate, for Patients with Advanced Solid Cancer Tumors · Share · Facebook · Twitter.

  9. Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation - Mayo Clinic

    The purpose of this study is to see if treating patients who have high levels of donor specific alloantibodies post-transplant with bortezomib might prevent the ...

  10. Convalescent plasma antibody levels and the risk of death from COVID-19 - Mayo Clinic News Network

    – Mayo Clinic researchers and collaborators have found an association between administration of convalescent plasma containing high antibodies and lower ...